Decreased DNA repair gene XRCC1 expression is associated with radiotherapy-induced acute side effects in breast cancer patients

Gene
Bahadir BatarMehmet Guven

Abstract

DNA repair plays a critical role in response to ionizing radiation (IR) and developing of radiotherapy induced normal tissue reactions. In our study, we investigated the association of radiotherapy related acute side effects, with X-ray repair cross complementing group 1 (XRCC1) and Poly (ADP-ribose) polymerase 1 (PARP1) DNA repair gene expression levels, their changes in protein expression and DNA damage levels in breast cancer patients. The study included 40 women with newly diagnosed breast cancer; an experimental case group (n=20) with acute side effects and the control group (n=20) without side effects. For gene and protein expression analysis, lymphocytes were cultured for 72 h and followed by in vitro 2 Gray (Gy) gamma-irradiation. For detection of DNA damage levels, lymphocytes were irradiated with in vitro 2 Gy gamma-rays and followed by incubation for 72 h. XRCC1 mRNA and protein expression levels were significantly higher in controls than in experimental cases (P=0.020). In terms of DNA damage levels, an increased frequency of micronucleus (MN) was observed in experimental cases versus controls, but this association was not significant (P=0.206). We also observed a significant negative correlation between MN frequenc...Continue Reading

References

Sep 21, 2002·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Christian Nicolaj AndreassenJens Overgaard
Dec 4, 2003·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Ulrike HoellerEkkehard Dikomey
Jul 8, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jenny Chang-ClaudeChristine B Ambrosone
Mar 31, 2007·Seminars in Radiation Oncology·Sylvie Delanian, Jean-Louis Lefaix
Jul 28, 2007·International Journal of Cancer. Journal International Du Cancer·Katrin WiebalkOdilia Popanda
Apr 15, 2008·International Journal of Radiation Oncology, Biology, Physics·Kerstin BorgmannEkkehard Dikomey
Nov 12, 2010·Breast Cancer Research and Treatment·Anthony GonçalvesFrançois Bertucci
Feb 25, 2011·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Tanja LangsenlehnerUwe Langsenlehner
Jun 5, 2012·Frontiers of Medicine·Zhifeng WangCaixia Guo
Feb 19, 2013·Expert Review of Proteomics·Jérôme LacombeJérôme Solassol
May 3, 2014·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Gillian C BarnettCatharine M L West
Sep 19, 2015·Seminars in Radiation Oncology·Sarah L KernsBarry S Rosenstein

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases
Na WangYi-Ming Wu
© 2021 Meta ULC. All rights reserved